Related Experiment Video
Updated: Aug 30, 2025
Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Computed tomography coronary angiography in non-ST-segment elevation myocardial infarction
Kang-Ling Wang1,2,3, Mohammed N Meah1, Anda Bularga1
1Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
Insights
Computed tomography coronary angiography (CTCA) helps diagnose non-ST-segment elevation myocardial infarction, reducing unnecessary invasive procedures. While effective, its impact on major adverse cardiovascular events requires further study.
Area of Science:
- Cardiology
- Medical Imaging
- Diagnostic Technologies
Background:
- Standard evaluation for non-ST-segment elevation myocardial infarction (NSTEMI) involves electrocardiography and troponin testing, followed by invasive angiography.
- Current diagnostic pathways for NSTEMI can present challenges in diagnosis, management, and patient outcomes.
- Computed tomography coronary angiography (CTCA) is emerging as a valuable tool in the assessment of suspected NSTEMI.
Purpose of the Study:
- To review the current evidence on the clinical application of CTCA in patients with suspected or diagnosed NSTEMI.
- To highlight the role of CTCA in optimizing the diagnostic and management pathway for NSTEMI.
- To identify areas where CTCA may expand its impact on patient care and outcomes.
Main Methods:
- Review of existing clinical evidence and studies on the utilization of CTCA in NSTEMI patients.
- Analysis of CTCA's performance in guiding invasive coronary angiography and reducing non-invasive functional testing.
- Examination of CTCA's utility in identifying myocardial infarction with no obstructive coronary artery disease (MINOCA) and alternative diagnoses.
Main Results:
- CTCA demonstrates significant value in avoiding unnecessary invasive coronary angiography and reducing downstream testing for myocardial ischemia.
- CTCA provides crucial complementary information for patients with MINOCA and aids in diagnosing other causes of troponin elevation.
- The impact of routine CTCA application on major adverse cardiovascular events has not yet been conclusively demonstrated.
Conclusions:
- CTCA serves as an effective gatekeeper for the cardiac catheterization laboratory in the context of NSTEMI.
- Ongoing research into CTCA and related technologies is expected to further define and potentially broaden its clinical applications in NSTEMI.
- CTCA is poised to play an increasingly important role in the diagnosis and management of patients with NSTEMI.
Abstract:
Electrocardiography and high-sensitivity cardiac troponin testing are routinely applied as the initial step for clinical evaluation of patients with suspected non-ST-segment elevation myocardial infarction. Once diagnosed, patients with non-ST-segment elevation myocardial infarction are commenced on antithrombotic and secondary preventative therapies before undergoing invasive coronary angiography to determine the strategy of coronary revascularisation. However, this clinical pathway is imperfect and can lead to challenges in the diagnosis, management, and clinical outcomes of these patients. Computed tomography coronary angiography (CTCA) has increasingly been utilised in the setting of patients with suspected non-ST-segment elevation myocardial infarction, where it has an important role in avoiding unnecessary invasive coronary angiography and reducing downstream non-invasive functional testing for myocardial ischaemia. CTCA is an excellent gatekeeper for the cardiac catheterisation laboratory. In addition, CTCA provides complementary information for patients with myocardial infarction in the absence of obstructive coronary artery disease and highlights alternative or incidental diagnoses for those with cardiac troponin elevation. However, the routine application of CTCA has yet to demonstrate an impact on subsequent major adverse cardiovascular events. There are several ongoing studies evaluating CTCA and its associated technologies that will define and potentially expand its application in patients with suspected or diagnosed non-ST-segment elevation myocardial infarction. We here review the current evidence relating to the clinical application of CTCA in patients with non-ST-segment elevation myocardial infarction and highlight the areas where CTCA is likely to have an increasing important role and impact for our patients.
More Related Videos
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
01:28Imaging Studies for Cardiovascular System V: CT
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:10Computed Tomography
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
01:21Imaging Studies for Cardiovascular System IV: CMRI
01:30Acute Coronary Syndrome I: Introduction